This is the authors' abstract. We don't add key points for this paper.
Australia has maintained a low prevalence of HIV, with a mainly concentrated epidemic and successful public health response. With the widespread availability of HIV genotyping for resistance testing, and development of phylogenetic methodologies, the field of molecular epidemiology has evolved a deeper understanding of diversity and transmission dynamics of HIV. Studies combining HIV genotype with epidemiological data have allowed insights to be gained into the changing subtype diversity, rates of transmitted drug resistance and transmission networks of HIV in Australia. This review provides an overview of HIV molecular epidemiology studies in Australia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pinto et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: